Cui Xiangmin — SEC Form 4 filings
SEC reporting owner CIK 1487815. 29 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2024-01-22 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 5 filings — 2,827,895 shares, $37,517,734 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 63 legs across 17 filings — 854,615 shares, $2,019,942 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 36.
- Largest priced transaction: purchase of 625,000 shares @ $16.00 ($10,000,000) in Aardvark Therapeutics, Inc., filed 2025-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | 10% owner | 1 | 2 legs · 1,250,000 sh · $20,000,000 | — | 4 |
| CG Oncology, Inc. (CGON) | 10% owner | 2 | 2 legs · 800,000 sh · $15,200,000 | — | 4 |
| Nuvation Bio Inc. (NUVB) | Director | 7 | 4 legs · 777,895 sh · $2,317,734 | — | 18 |
| BeyondSpring Inc. (BYSI) | 10% owner | 17 | — | 63 legs · 854,615 sh · $2,019,942 | — |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) | Director, 10% owner | 2 | — | — | 10 |
Form 4 filings — Cui Xiangmin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-26 | 4/A | Nuvation Bio Inc. (NUVB) | Grant/award (A): 76,923 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 123,397 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 74,813 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 85,798 @ $1.72 · Sale (S): 45,513 @ $1.76 | EDGAR |
| 2025-10-15 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 107,361 @ $1.70 · Sale (S): 28,495 @ $1.65 · Sale (S): 17,960 @ $1.65 | EDGAR |
| 2025-10-10 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 7,507 @ $1.77 · Sale (S): 3,979 @ $1.81 · Sale (S): 2,390 @ $1.77 | EDGAR |
| 2025-10-07 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 600 @ $1.76 · Sale (S): 17,500 @ $1.78 · Sale (S): 2,100 @ $1.79 | EDGAR |
| 2025-10-02 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 4,464 @ $1.81 · Sale (S): 2,601 @ $1.80 · Sale (S): 600 @ $1.73 | EDGAR |
| 2025-09-29 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 700 @ $1.66 · Sale (S): 600 @ $1.68 · Sale (S): 500 @ $1.75 | EDGAR |
| 2025-09-24 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 5,410 @ $1.83 · Sale (S): 4,106 @ $1.72 · Sale (S): 2,256 @ $1.68 | EDGAR |
| 2025-09-19 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 2,304 @ $1.83 · Sale (S): 5,307 @ $1.74 · Sale (S): 3,656 @ $1.79 | EDGAR |
| 2025-09-16 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 700 @ $1.85 · Sale (S): 2,570 @ $1.84 · Sale (S): 840 @ $1.88 | EDGAR |
| 2025-09-11 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 9,050 @ $1.97 · Sale (S): 8,176 @ $1.93 · Sale (S): 3,820 @ $1.90 | EDGAR |
| 2025-09-08 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 803 @ $1.82 · Sale (S): 1,106 @ $1.86 · Sale (S): 7,090 @ $1.93 | EDGAR |
| 2025-09-03 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 800 @ $1.74 · Sale (S): 2,800 @ $1.78 · Sale (S): 1,270 @ $1.81 | EDGAR |
| 2025-08-28 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 2,000 @ $1.79 · Sale (S): 1,300 @ $1.78 · Sale (S): 809 @ $1.81 | EDGAR |
| 2025-08-25 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 3,034 @ $1.79 · Sale (S): 2,376 @ $1.75 · Sale (S): 300 @ $1.77 | EDGAR |
| 2025-08-20 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 47,668 @ $2.03 · Sale (S): 3,604 @ $1.77 · Sale (S): 3,456 @ $1.74 | EDGAR |
| 2025-08-15 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 2,000 @ $2 · Sale (S): 2,900 @ $2 | EDGAR |
| 2025-08-11 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Sale (S): 5,000 @ $3.23 · Sale (S): 59,253 @ $3.17 · Sale (S): 60,000 @ $3.11 · Sale (S): 225,217 @ $3.16 · Sale (S): 1,700 @ $3.09 · Sale (S): 600 @ $2.43 · +11 more | EDGAR |
| 2025-02-19 | 4 | Aardvark Therapeutics, Inc. (AARD) jointly with Decheng Capital Global Life Sciences Fund IV, L.P., Decheng Capital Management IV (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Conversion (C): 2,333,887 · Conversion (C): 333,412 · Purchase (P): 625,000 @ $16 · Purchase (P): 625,000 @ $16 · Conversion (C): 19,777,363 (derivative) @ $0 · Conversion (C): 2,825,337 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Nuvation Bio Inc. (NUVB) | Conversion (C): 967,100 · Conversion (C): 5,157,900 · Conversion (C): 12,879,200 · Grant/award (A): 9,671 (derivative) · Grant/award (A): 51,579 (derivative) · Grant/award (A): 128,792 (derivative) · +6 more | EDGAR |
| 2024-06-26 | 4 | Nuvation Bio Inc. (NUVB) | Purchase (P): 277,895 @ $2.97 | EDGAR |
| 2024-06-25 | 4 | Nuvation Bio Inc. (NUVB) | Purchase (P): 87,715 @ $2.99 · Purchase (P): 75,411 @ $3 · Purchase (P): 336,874 @ $2.98 | EDGAR |
| 2024-05-20 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Code (U): 6,582,380 · Code (U): 1,735,544 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2024-04-11 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 314,106 · Grant/award (A): 1,675,236 · Grant/award (A): 4,183,002 | EDGAR |
| 2024-04-09 | 4/A | CG Oncology, Inc. (CGON) jointly with Decheng Capital Global Life Sciences Fund IV, L.P., Decheng Capital Management IV (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Purchase (P): 400,000 @ $19 | EDGAR |
| 2024-01-31 | 4 | CG Oncology, Inc. (CGON) jointly with Decheng Capital Global Life Sciences Fund IV, L.P., Decheng Capital Management IV (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Conversion (C): 3,628,198 · Purchase (P): 400,000 @ $19 · Conversion (C): 8,644,891 (derivative) · Conversion (C): 21,547,685 (derivative) · Conversion (C): 4,402,320 (derivative) | EDGAR |
| 2024-01-22 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Option exercise/expiry (X): 1,234,636 @ $12.74 · Option exercise/expiry (X): 1,234,636 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1487815 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →